Resources
Search our resources for user guides, checklists, international scientific guidelines, compositional guidelines and forms.
Can't find what you’re looking for? You can also:
- search our Publications
- use the site search bar in the top right of this screen for more results.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Safety monitoring and information (51)
- Clinical trials (44)
- Legislation (24)
- Manufacturing (23)
- Import and export (10)
- Compliance and enforcement (8)
- Advertising (5)
- Labelling and packaging (4)
- Medicinal cannabis hub (4)
- Shortages and supply disruptions (3)
- Vaping hub (3)
- Committees and advisory bodies (2)
- Fees and payments (2)
- Scheduling (national classification system) (2)
- Unique Device Identification (UDI) hub (1)
Search
637 result(s) found, displaying 576 to 600
-
Compositional guidelinesCompositional guideline for 'Amylase' permitted for use in listed medicines
-
Compositional guidelinesCompositional guideline for 'Cellulase' permitted for use in listed medicines
-
Compositional guidelinesCompositional guideline for 'Deer velvet antler slice' permitted for use in listed medicines
-
Compositional guidelinesCompositional guideline for 'Magnesium citrate - dibasic tetrahydrate' permitted for use in listed medicines
-
Compositional guidelinesCompositional guideline for 'Fish oil - natural' permitted for use in listed medicines
-
Compositional guidelinesCompositional guideline for 'Alpha-casozepine enriched hydrolysed milk protein' permitted for use in listed medicines
-
Compositional guidelinesCompositional guideline for 'Zeaxanthin' permitted for use in listed medicines
-
FormsThe Registered medicine variation form (complementary medicines) should only be used when you wish to vary the particulars of complementary medicines which are already registered in the ARTG.
-
FormsThis form should only be used when you wish to apply for registration of a new complementary medicine that would be 'grouped' with a medicine already registered on the Australian Register of Therapeutic Goods (ARTG).
-
Compositional guidelinesCompositional guideline for 'Demineralised fish proteoglycan extract' permitted for use in listed medicines
-
Compositional guidelinesCompositional guideline for 'Arthrospira maxima' permitted for use in listed medicines
-
Compositional guidelinesCompositional guideline for 'Arthrospira platensis' permitted for use in listed medicines
-
Compositional guidelinesCompositional guideline for 'Black boned chicken powder' permitted for use in listed medicines
-
Compositional guidelinesCompositional guideline for 'Bovine colostrum powder' permitted for use in listed medicines
-
Compositional guidelinesCompositional guideline for 'Conifer phytosterol complex' permitted for use in listed medicines
-
-
International scientific guidelines adopted in AustraliaAccess European Union guidelines adopted in Australia that are related to complementary medicines.
-
International scientific guidelines adopted in AustraliaInternational Scientific Guideline - (CPMP/QWP/2820/00) EMEA/CVMP/815/00
-
International scientific guidelines adopted in AustraliaInternational scientific guideline - (CPMP/QWP/2819/00) EMEA/CVMP/814/00
-
User guideFinished product (medicine) analytical procedure validations for complementary medicines.
-
International scientific guidelines adopted in AustraliaWe have adopted this International Scientific Guideline - EMEA/CHMP/BMWP/118264/2007 Rev. 1.
-
International scientific guidelines adopted in AustraliaWe have adopted this International Scientific Guideline - EMA/INS/GCP/856758/2018
-
International scientific guidelines adopted in AustraliaCOMP/431/01 adopted by the Therapeutic Goods Administration (TGA)
-
International scientific guidelines adopted in AustraliaWe have adopted this International Scientific Guideline – ICH Q4B Annex 5; EMA/CHMP/ICH/308895/2008
-
International scientific guidelines adopted in AustraliaWe have adopted this International Scientific Guideline – ICH Q11; EMA/CHMP/ICH/425213/2011